The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation
Abstract
The secreted form of beta-amyloid precursor protein (APP) containing the Kunitz proteinase inhibitor (KPI) domain, also called protease nexin II, is internalized and degraded by cells. We show that the low density lipoprotein (LDL) receptor-related protein (LRP) is responsible for the endocytosis of secreted APP. APPs770 degradation is inhibited by an LRP antagonist called the receptor-associated protein (RAP) and by LRP antibodies and is greatly diminished in fibroblasts genetically deficient in LRP. APPs695, which lacks the KPI domain, is a poor LRP ligand. Since LRP also binds apolipoprotein E (apoE)-enriched lipoproteins and inheritance of the epsilon 4 allele of the apoE gene is a risk factor for Alzheimer's disease (AD), these data link in a single metabolic pathway two molecules strongly implicated in the pathophysiology of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
An interaction between the C-terminal domain of APP and LRP, mediated by the cytoplasmic adaptor protein Fe65, impacts APP internalization.
“In addition, an interaction between the C-terminal domain of APP and LRP, mediated by the cytoplasmic adaptor protein Fe65, impacts APP internalization (18 -23).”
From The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel β-Secretase (BACE1) Substrate (2005) · cites this paper as [18]
LRP's four extracellular binding domains mediate endocytosis of a wide array of ligands, including APP, apolipoprotein E and α2-macroglobulin.
“its four extracellular binding domains mediate endocytosis of a wide array of ligands, including several of potential importance for Alzheimer disease pathophysiology: APP, apolipoprotein E and ␣ 2 -macroglobulin (16 -18).”
From The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel β-Secretase (BACE1) Substrate (2005) · cites this paper as [18]
LRP1 plays roles in lipid metabolism, protein clearance, and cell signaling.
“LRP1, a well‐known receptor playing roles in lipid metabolism, 28 protein clearance, 29 and cell signaling, 30 , 31”
RAP is a well-known LRP1 antagonist that binds LRP1 and reduces its ligand binding capacity.
“we tested the effects of receptor associated protein (RAP), a well‐known LRP1 antagonist that binds LRP1 and reduces its ligand binding capacity. 29 , 34”
Binding/uptake studies in mouse embryonic fibroblasts confirmed that free Aβ is not a ligand for LRP-1.
“Binding/uptake studies in mouse embryonic fibroblasts (wild type and deficient in LRP-1), confirmed that free A b is not a ligand for LRP-1 (37, 45).”
From Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier (2000) · cites this paper as [45]
LRP mediates endocytosis of a secreted form of amyloid precursor protein.
“LRP has been shown to mediate the endocytosis of a secreted form of amyloid precursor protein (34).”
From Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures (2000) · cites this paper as [34]
Citations
Cites
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus
Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) · Science · doi:10.1126/science.2949367 · Cited by 1,611
Self-citation
Flagged first, then by citations
Research works printed but not linked: 62
- Abe, 1991, Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex, Neurosci. Lett., 125, 172, 10.1016/0304-3940(91)90020-T · DOI
- Ashcom, 1990, The human α2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of α2-macroglobulin, J. Cell Biol., 110, 1041, 10.1083/jcb.110.4.1041 · DOI
- Battey, 1994, The 39 kDa receptor associated protein regulates ligand binding by the very low density lipoprotein receptor, J. Biol. Chem., 269, 23268, 10.1016/S0021-9258(17)31648-4 · DOI
- Beisiegel, 1989, The LDL-receptor related protein, LRP, is an apolipoprotein E binding protein, Nature, 341, 162, 10.1038/341162a0 · DOI
- Breen, 1992, APP-collagen interaction is mediated by a heparin bridge mechanism, Mol. Chem. Neuropathol., 16, 109, 10.1007/BF03159964 · DOI
- Breen, 1991, β amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion, J. Neurosci. Res., 28, 90, 10.1002/jnr.490280109 · DOI
- Bush, 1993, A novel zinc(II) binding site modulates the function of the (3A4 amyloid protein precursor of Alzheimer's disease, J. Biol. Chem., 268, 16109, 10.1016/S0021-9258(19)85394-2 · DOI
- Chappell, 1993, Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/α2-macroglobulin receptor in vitro: a process facilitated by cell-surface proteoglycans, J. Biol. Chem., 268, 14168, 10.1016/S0021-9258(19)85223-7 · DOI
- Esch, 1990, Cleavage of amyloid β-peptide during constitutive processing of its precursor, Science, 248, 1122, 10.1126/science.2111583 · DOI
- Glenner, 1984, Initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun., 120, 885, 10.1016/S0006-291X(84)80190-4 · DOI · Paper page
- Godyna, 1995, Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1, J. Cell. Biol., 129, 1403, 10.1083/jcb.129.5.1403 · DOI
- Golde, 1992, Processing of the amyloid protein precursor to potentially amyloidogenic derivatives, Science, 255, 728, 10.1126/science.1738847 · DOI
- Haass, 1992, Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments, Nature, 357, 500, 10.1038/357500a0 · DOI
- Herz, 1991, 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/α2-rmacroglobulin receptor, J. Biol. Chem., 266, 21232, 10.1016/S0021-9258(18)54845-6 · DOI
- Hyman, 1992, Kunitz protease inhibitor containing amyloid precursor protein immunoreactivity in Alzheimer's disease, J. Neuropathol. Exp. Neurol., 51, 76, 10.1097/00005072-199201000-00009 · DOI
- Jin, 1994, Peptides containing the RERMS sequence of amyloid βA4 protein precursor bind to cell surfaces and promote neurite extension, J. Neurosci., 14, 5461, 10.1523/JNEUROSCI.14-09-05461.1994 · DOI
- Johnson-Wood, 1994, Identification of secreted 6-amyloid precursor protein binding sites on intact human fibroblasts, Biochem. Biophys. Res. Commun., 200, 1685, 10.1006/bbrc.1994.1646 · DOI
- Kitaguchi, 1988, Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity, Nature, 331, 530, 10.1038/331530a0 · DOI
- Knauer, 1983, Protease nexins: cell-secreted proteins that mediate the binding, internalization, and degradation of regulatory seririe proteases, J. Cell Physiol., 117, 385, 10.1002/jcp.1041170314 · DOI
- Koo, 1990, Differential expression of amyloid precursor protein mRNAs in cases of Alzheimer's disease and in aged nonhuman primates, Neuron, 2, 97, 10.1016/0896-6273(90)90446-M · DOI
- Kounnas, 1992, The 39-kDa receptor-associated protein interacts with two members of the low density lipoprotein receptor family, α2-macroglobulin receptor and glycoprotein 330, J. Biol. Chem., 267, 21162, 10.1016/S0021-9258(19)36811-5 · DOI
- Kounnas, 1992, The α2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A, J. Biol. Chem., 267, 12420, 10.1016/S0021-9258(18)42291-0 · DOI
- Kounnas, 1993, Low density lipoprotein receptor-related protein/α2-macroglobulin receptor mediates cellular uptake of pro-urokinase, J. Biol. Chem., 268, 21862, 10.1016/S0021-9258(20)80620-6 · DOI
- Kounnas, 1994, Immunological localization of glycoprotein 330, low density lipoprotein receptor related protein and 39 kDa receptor associated protein in embryonic mouse tissue, In Vivo, 8, 342
- Kounnas, 1995, The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans, J. Biol. Chem., 270, 9307, 10.1074/jbc.270.16.9307 · DOI
- Kowal, 1990, Opposing effects of apolipoproteins E and C on lipoprotein binding to LDL receptor related protein, J. Biol. Chem., 265, 10771, 10.1016/S0021-9258(18)87014-4 · DOI · Paper page
- Krieger, 1994, Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP), Annu. Rev. Biochem., 63, 601, 10.1146/annurev.bi.63.070194.003125 · DOI
- Mahley, 1988, Apolipoprotein E: cholesterol transport protein with expanding role in cell biology, Science, 240, 622, 10.1126/science.3283935 · DOI · Paper page
- Masters, 1985, Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels, EMBO J., 4, 27572763, 10.1002/j.1460-2075.1985.tb04000.x · DOI
- Mattson, 1993, Evidence for excito-protective and intraneuronal calcium-regulating roles for secreted formsof the β-amyloid precursor protein, Neuron, 10, 243, 10.1016/0896-6273(93)90315-I · DOI
- Medh, 1995, The 39 kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors, J. Biol. Chem., 270, 536, 10.1074/jbc.270.2.536 · DOI · Paper page
- Mikhailenko, 1995, Low density lipoprotein receptor-related protein/α2M receptor mediates the cellular internalization and degradation of thrombospondin: a process facilitated by cell-surface proteoglycans, J. Biol. Chem., 270, 9543, 10.1074/jbc.270.16.9543 · DOI
- Moestrup, 1989, Purification of the rat hepatic armacroglobulin receptor as an approximately 440 kDa single chain polypeptide, J. Biol. Chem., 264, 15574, 10.1016/S0021-9258(19)84870-6 · DOI
- Moestrup, 1992, Distribution of the α2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues, Cell Tissue Res., 269, 375, 10.1007/BF00353892 · DOI
- Moir, 1992, Human brain βA4 amyloid protein precursor (APP) of Alzheimer's disease: purification and partial characterization, J. Neurochem., 59, 1490, 10.1111/j.1471-4159.1992.tb08465.x · DOI
- Nathan, 1994, Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro, Science, 264, 850, 10.1126/science.8171342 · DOI · Paper page
- Nykjaer, 1994, Regions involved in binding of urokinase-type I inhibitor complex and pro-urokinase to the endocytic α2-macroglobulin receptor/lowdensity lipoprotein receptor-related protein, J. Biol. Chem., 269, 25668, 10.1016/S0021-9258(18)47301-2 · DOI
- Nykjaer, 1992, Purified α2-macroglobulin receptor/LDL receptor-related protein binds urokinase plasminogen activator inhibitor type-1 complex: evidence that the α2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes, J. Biol. Chem., 267, 14543, 10.1016/S0021-9258(18)42072-8 · DOI
- Oltersdorf, 1989, The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II, Nature, 341, 144, 10.1038/341144a0 · DOI
- Poirier, 1993, Apolipoprotein E polymorphism and Alzheimer's, Lancet, 342, 697, 10.1016/0140-6736(93)91705-Q · DOI · Paper page
- Poller, 1995, Differential recognition of α1-antitrypsin-elastase and α1-antichymotrypsin-cathepsin G complexes by the low density lipoprotein receptor-related protein, J. Biol. Chem., 270, 2841, 10.1074/jbc.270.6.2841 · DOI
- Qui, 1995, Cell-surface β amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an isoform-dependent manner, J. Neurosci., 15, 2157, 10.1523/JNEUROSCI.15-03-02157.1995 · DOI
- Rebeck, 1993, Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions, Neuron, 11, 575, 10.1016/0896-6273(93)90070-8 · DOI · Paper page
- Rebeck, 1995, Multiple, diverse senile plaque-associated proteins are ligands for an apolipoprotein E receptor, the α2-macroglobulin receptor/low density lipoprotein receptor related protein, Ann. Neurol., 37, 211, 10.1002/ana.410370212 · DOI · Paper page
- Sakai, 1994, Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene, J. Biol. Chem., 269, 2173, 10.1016/S0021-9258(17)42151-X · DOI
- Saunders, 1993, Association of apolipoprotein E allele 04 with late-onset familial and sporadic Alzheimer's disease, Neurology, 43, 1467, 10.1212/WNL.43.8.1467 · DOI · Paper page
- Schmaier, 1993, Protease nexin-2/amyloid β protein precursor. A tight-binding inhibitor of coagulation factor IXa, J. Clin. Invest., 92, 2540, 10.1172/JCI116863 · DOI
- Sisodia, 1990, Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing, Science, 248, 492, 10.1126/science.1691865 · DOI
- Slunt, 1994, Expression of a ubiquitous, cross-reactive homologue of the mouse β-amyloid precursor protein (APP), J. Biol. Chem., 269, 2637, 10.1016/S0021-9258(17)41992-2 · DOI
- Strickland, 1990, Sequence identity between the α2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor, J. Biol. Chem., 265, 17401, 10.1016/S0021-9258(18)38172-9 · DOI
- Strickland, 1991, Primary structure of α2-macroglobulin receptor-associated protein: human homologue of a Heymann nephritis antigen, J. Biol. Chem., 266, 13364, 10.1016/S0021-9258(18)98848-4 · DOI
- Strickland, 1995, LDL receptor-related protein (LRP): a multiligand receptor for lipoprotein and proteinase catabolism, FASEB J., 10.1096/fasebj.9.10.7615159 · DOI
- Tanzi, 1988, Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease, Nature, 331, 528, 10.1038/331528a0 · DOI
- Van Nostrand, 1987, Purification of protease nexin II from human fibroblasts, J. Biol. Chem., 262, 8508, 10.1016/S0021-9258(18)47443-1 · DOI
- Van Nostrand, 1989, Protease nexin-II, a potent antichymotrypsin, shows identity to the amyloid β-protein precursor, Nature, 341, 546, 10.1038/341546a0 · DOI
- Van Nostrand, 1990, Immunopurification and protease inhibitory properties of protease nexin-2/amyloid β-protein precursor, J. Biol. Chem., 265, 9591, 10.1016/S0021-9258(19)38706-X · DOI
- Wasco, 1993, Isolation and characterization of the human APLP2 gene encoding a homologue of the Alzheimer's associated β protein precursor, Nature Genet., 5, 95, 10.1038/ng0993-95 · DOI
- Williams, 1992, A novel mechanism for controlling the activity of a2-macroglobulin receptor/low density lipoprotein receptor-related protein: multiple regulatory sites for 39-kDa receptor-associated protein, J. Biol. Chem., 267, 9035, 10.1016/S0021-9258(19)50384-2 · DOI
- Willnow, 1994, Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A: evidence that this protein is required for uptake and degradation of multiple ligands, J. Cell Sci., 107, 719, 10.1242/jcs.107.3.719 · DOI
- Willnow, 1992, LDL receptor related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance, J. Biol. Chem., 267, 26172, 10.1016/S0021-9258(18)35732-6 · DOI
- Yamamoto, 1984, The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA, Cell, 39, 27, 10.1016/0092-8674(84)90188-0 · DOI · Paper page
- Zheng, 1994, Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/α2-macroglobulin receptor, and the receptorassociated protein (RAP), J. Histochem. Cytochem., 42, 531, 10.1177/42.4.7510321 · DOI
Cited by
Sorted by citations
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00269-y · Cited by 2,606
Self-citationApolipoprotein E: Far More Than a Lipid Transport Protein
Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
Self-citationSynergy between amyloid-β and tau in Alzheimer’s disease
Busche, M. A., & Hyman, B. T. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0687-6 · Cited by 1,242
Self-citationA Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60
Cao, X., & Südhof, T. C. (2001) · Science · doi:10.1126/science.1058783 · Cited by 1,202
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
Bu, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2620 · Cited by 1,168
LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms
Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., Xu, F., Parisi, M., LaRue, B., Hu, H. W., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.017 · Cited by 828
Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
Holtzman, D. M., Herz, J., & Bu, G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006312 · Cited by 782
Asuni, A. A., Boutajangout, A., Quartermain, D., & Sigurdsson, E. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2361-07.2007 · Cited by 506
Lipoprotein receptors in the nervous system
Herz, J., & Bock, H. H. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135342 · Cited by 457
Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier
Lajoie, J. M., & Shusta, E. V. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124852 · Cited by 399
Kang, D. E., Pietrzik, C. U., Baum, L., Chevallier, N., Merriam, D. E., Kounnas, M. Z., Wagner, S. L., Troncoso, J. C., Kawas, C. H., Katzman, R., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11013 · Cited by 354
Self-citationHoltzman, D. M., Bales, K. R., Wu, S., Bhat, P., Parsadanian, M., Fagan, A. M., Chang, L. K., Sun, Y., & Paul, S. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6179 · Cited by 349
Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease
Baranello, R., Bharani, K., Padmaraju, V., Chopra, N., Lahiri, D., Greig, N., Pappolla, M., & Sambamurti, K. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666141218140953 · Cited by 331
Apolipoprotein E4 effects in Alzheimer’s disease are mediated by synaptotoxic oligomeric amyloid-β
Koffie, R. M., Hashimoto, T., Tai, H.-C., Kay, K. R., Serrano-Pozo, A., Joyner, D., Hou, S., Kopeikina, K. J., Frosch, M. P., Lee, V. M., et al. (2012) · Brain · doi:10.1093/brain/aws127 · Cited by 327
Self-citationLiang, W. S., Dunckley, T., Beach, T. G., Grover, A., Mastroeni, D., Ramsey, K., Caselli, R. J., Kukull, W. A., McKeel, D., Morris, J. C., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00242.2007 · Cited by 309
Metal complexing agents as therapies for Alzheimer’s disease
Bush, A. I. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00120-3 · Cited by 310
Self-citationAlexander, A. G., Marfil, V., & Li, C. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00279 · Cited by 310
Shinohara, M., Tachibana, M., Kanekiyo, T., & Bu, G. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075796 · Cited by 297
Fagan, A. M., Watson, M., Parsadanian, M., Bales, K. R., Paul, S. M., & Holtzman, D. M. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0483 · Cited by 290
Kanekiyo, T., & Bu, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00093 · Cited by 281
Willnow, T. E., Rohlmann, A., Horton, J., Otani, H., Braun, J. R., Hammer, R. E., & Herz, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00623.x · Cited by 276
Ye, S., Huang, Y., Müllendorff, K., Dong, L., Giedt, G., Meng, E. C., Cohen, F. E., Kuntz, I. D., Weisgraber, K. H., & Mahley, R. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508693102 · Cited by 275
The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel β-Secretase (BACE1) Substrate
von Arnim, C. A. F., Kinoshita, A., Peltan, I. D., Tangredi, M. M., Herl, L., Lee, B. M., Spoelgen, R., Hshieh, T. T., Ranganathan, S., Battey, F. D., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414248200 · Cited by 258
Self-citationKuo, Y.-M., Kokjohn, T. A., Kalback, W., Luehrs, D., Galasko, D. R., Chevallier, N., Koo, E. H., Emmerling, M. R., & Roher, A. E. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2222 · Cited by 230
Ling, Y., Morgan, K., & Kalsheker, N. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00133-x · Cited by 224
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease
Cruchaga, C., Kauwe, J. S. K., Nowotny, P., Bales, K., Pickering, E. H., Mayo, K., Bertelsen, S., Hinrichs, A., Fagan, A. M., Holtzman, D. M., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds296 · Cited by 207
Georgieva, J., Hoekstra, D., & Zuhorn, I. (2014) · Pharmaceutics · doi:10.3390/pharmaceutics6040557 · Cited by 211
Pietrzik, C. U., Busse, T., Merriam, D. E., Weggen, S., & Koo, E. H. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf568 · Cited by 198
Phase I Study of GRN1005 in Recurrent Malignant Glioma
Drappatz, J., Brenner, A., Wong, E. T., Eichler, A., Schiff, D., Groves, M. D., Mikkelsen, T., Rosenfeld, S., Sarantopoulos, J., Meyers, C. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2481 · Cited by 190
Molecular Genetics of Late‐Onset Alzheimer's Disease
Kamboh, M. I. (2004) · Annals of Human Genetics · doi:10.1046/j.1529-8817.2004.00110.x · Cited by 170
Insulin metabolism in Alzheimer’s disease differs according to apolipoprotein E genotype and gender
Craft, S., Asthana, S., Schellenberg, G., Cherrier, M., Baker, L. D., Newcomer, J., Plymate, S., Latendresse, S., Petrova, A., Raskind, M., et al. (1999) · Neuroendocrinology · doi:10.1159/000054469 · Cited by 154
Thal, D. R., Schultz, C., Dehghani, F., Yamaguchi, H., Braak, H., & Braak, E. (2000) · Acta Neuropathologica · doi:10.1007/s004010000242 · Cited by 136
Zerbinatti, C. V., Wozniak, D. F., Cirrito, J., Cam, J. A., Osaka, H., Bales, K. R., Zhuo, M., Paul, S. M., Holtzman, D. M., & Bu, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305803101 · Cited by 133
Zerbinatti, C. V., Wahrle, S. E., Kim, H., Cam, J. A., Bales, K., Paul, S. M., Holtzman, D. M., & Bu, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604436200 · Cited by 129
Marzolo, M.-P., & Bu, G. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.10.005 · Cited by 122
Cooper, J. M., Lathuiliere, A., Migliorini, M., Arai, A. L., Wani, M. M., Dujardin, S., Muratoglu, S. C., Hyman, B. T., & Strickland, D. K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100715 · Cited by 122
Self-citationHoe, H.-S., Wessner, D., Beffert, U., Becker, A. G., Matsuoka, Y., & Rebeck, G. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9259-9268.2005 · Cited by 122
Self-citationImmunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies
Sigurdsson, E. M. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15202 · Cited by 116
Functional Roles of the Interaction of APP and Lipoprotein Receptors
Pohlkamp, T., Wasser, C. R., & Herz, J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00054 · Cited by 92
Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures
LaDu, M. J., Shah, J. A., Reardon, C. A., Getz, G. S., Bu, G., Hu, J., Guo, L., & Van Eldik, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000602200 · Cited by 103
Irizarry, M. C., Cheung, B. S., Rebeck, G. W., Paul, S. M., Bales, K. R., & Hyman, B. T. (2000) · Acta Neuropathologica · doi:10.1007/s004010000263 · Cited by 93
Self-citationVan Uden, E., Mallory, M., Veinbergs, I., Alford, M., Rockenstein, E., & Masliah, E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09298.2002 · Cited by 91
Role of amyloid beta in lipid homeostasis
Grösgen, S., Grimm, M. O. W., Frieß, P., & Hartmann, T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.05.002 · Cited by 90
Choi, H. Y., Liu, Y., Tennert, C., Sugiura, Y., Karakatsani, A., Kröger, S., Johnson, E. B., Hammer, R. E., Lin, W., & Herz, J. (2013) · eLife · doi:10.7554/elife.00220 · Cited by 71
FE65 interaction with the ApoE receptor ApoEr2
Hoe, H.-S., Magill, L. A., Guenette, S., Fu, Z., Vicini, S., & Rebeck, G. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600728200 · Cited by 69
Self-citationThe generation and function of soluble apoE receptors in the CNS
Rebeck, G. W., LaDu, M. J., Estus, S., Bu, G., & Weeber, E. J. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-15 · Cited by 66
Self-citationCampos-Peña, V., Toral-Rios, D., Becerril-Pérez, F., Sánchez-Torres, C., Delgado-Namorado, Y., Torres-Ossorio, E., Franco-Bocanegra, D., & Carvajal, K. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6768 · Cited by 58
Ranganathan, S., Noyes, N. C., Migliorini, M., Winkles, J. A., Battey, F. D., Hyman, B. T., Smith, E., Yepes, M., Mikhailenko, I., & Strickland, D. K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5065-10.2011 · Cited by 49
“LRP1 was discovered to bind to the amyloid precursor protein (APP) (Kounnas et al., 1995; Knauer et al., 1996; Kinoshita et al., 2001), a transmembrane protein that is proteolytically processed to generate the -amyloid (A ) peptide that is a major component of plaques in Alzheimer’s patients.”
BackgroundSelf-citationHyman, B. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-023749 · Cited by 39
Self-citationFE65 interacts with ADP-ribosylation factor 6 to promote neurite outgrowth
Cheung, H. N. M., Dunbar, C., Mórotz, G. M., Cheng, W. H., Chan, H. Y. E., Miller, C. C. J., & Lau, K. (2014) · The FASEB Journal · doi:10.1096/fj.13-232694 · Cited by 37
Xu, G., Karch, C., Li, N., Lin, N., Fromholt, D., Gonzales, V., & Borchelt, D. R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003159 · Cited by 14
Hovde, M. J., Maaser‐Hecker, A., Bae, J., & Tanzi, R. E. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70879 · Cited by 8
Self-citation
Metadata
- Authors
- Kounnas, M. Z., Moir, R. D., Rebeck, G. W., Bush, A. I., Argraves, W. S., Tanzi, R. E., Hyman, B. T., & Strickland, D. K.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1995-07
- Volume
- 82
- Issue
- 2
- Pages
- 331-340
- ISSN
- 0092-8674
- Cited by
- 401
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review